(NYSE: ALUR) Allurion Technologies's forecast annual revenue growth rate of 8% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.13%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.12%.
Allurion Technologies's revenue in 2025 is $19,917,000.On average, 1 Wall Street analysts forecast ALUR's revenue for 2025 to be $108,677,534, with the lowest ALUR revenue forecast at $108,677,534, and the highest ALUR revenue forecast at $108,677,534. On average, 1 Wall Street analysts forecast ALUR's revenue for 2026 to be $141,280,794, with the lowest ALUR revenue forecast at $141,280,794, and the highest ALUR revenue forecast at $141,280,794.
In 2027, ALUR is forecast to generate $291,100,538 in revenue, with the lowest revenue forecast at $291,100,538 and the highest revenue forecast at $291,100,538.